Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARBASTIR: Stiripentol and Carbamazepine in Pharmacoresistant Focal Epilepsy
NCT05419180Phase 4Completed
- Sponsor
- Biocodex
- Start
- Oct 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of stiripentol in focal epilepsy, sponsored by Biocodex. Started Oct 2022; status: completed.
02
Drugs
stiripentol
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT05419180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05419180.